Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleOMERACT 11

How to Choose Core Outcome Measurement Sets for Clinical Trials: OMERACT 11 Approves Filter 2.0

Maarten Boers, John R. Kirwan, Laure Gossec, Philip G. Conaghan, Maria-Antonietta D’Agostino, Clifton O. Bingham III, Peter M. Brooks, Robert Landewé, Lyn March, Lee Simon, Jasvinder A. Singh, Vibeke Strand, George A. Wells and Peter Tugwell
The Journal of Rheumatology May 2014, 41 (5) 1025-1030; DOI: https://doi.org/10.3899/jrheum.131314
Maarten Boers
From the Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands; University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Université Pierre et Marie Curie (UPMC) — Paris 6, GRC-UMPC 08 (EEMOIS), Paris, France; APHP, Hôpital Pitié-Salpêtrière, Rhumatologie; University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Rheumatology, APHP, Ambroise Paré Hospital, UPRES EA 2506 Université Versailles-Saint Quentin En Yvelines, Boulogne-Billancourt, France; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Australian Health Workforce Institute, School of Population Health, University of Melbourne, Melbourne, Australia; Academic Medical Center University of Amsterdam and Atrium Medical Center Heerlen, Heerlen, The Netherlands; Institute of Bone and Joint Research and Sydney Medical School and School of Public Health, University of Sydney, and Department of Rheumatology, Royal North Shore, St. Leonards, NSW, Australia; SDG LLC, Cambridge, Massachusetts; University of Alabama at Birmingham; Veterans Affairs Medical Center, Birmingham, Alabama; Mayo Clinic College of Medicine, Rochester, Minnesota; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Department of Epidemiology and Community Medicine, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: eb@vumc.nl
John R. Kirwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laure Gossec
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip G. Conaghan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria-Antonietta D’Agostino
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clifton O. Bingham III
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter M. Brooks
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Landewé
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lyn March
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lee Simon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jasvinder A. Singh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vibeke Strand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George A. Wells
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Tugwell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading

Article Information

vol. 41 no. 5 1025-1030
DOI 
https://doi.org/10.3899/jrheum.131314
PubMed 
24584913

Published By 
The Journal of Rheumatology
Print ISSN 
0315-162X
Online ISSN 
1499-2752
History 
  • Published online May 1, 2014.

Article Versions

  • Latest version (March 1, 2014 - 04:00).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2014

Author Information

  1. Maarten Boers⇑,
  2. John R. Kirwan,
  3. Laure Gossec,
  4. Philip G. Conaghan,
  5. Maria-Antonietta D’Agostino,
  6. Clifton O. Bingham III,
  7. Peter M. Brooks,
  8. Robert Landewé,
  9. Lyn March,
  10. Lee Simon,
  11. Jasvinder A. Singh,
  12. Vibeke Strand,
  13. George A. Wells and
  14. Peter Tugwell
  1. From the Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands; University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Université Pierre et Marie Curie (UPMC) — Paris 6, GRC-UMPC 08 (EEMOIS), Paris, France; APHP, Hôpital Pitié-Salpêtrière, Rhumatologie; University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Rheumatology, APHP, Ambroise Paré Hospital, UPRES EA 2506 Université Versailles-Saint Quentin En Yvelines, Boulogne-Billancourt, France; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Australian Health Workforce Institute, School of Population Health, University of Melbourne, Melbourne, Australia; Academic Medical Center University of Amsterdam and Atrium Medical Center Heerlen, Heerlen, The Netherlands; Institute of Bone and Joint Research and Sydney Medical School and School of Public Health, University of Sydney, and Department of Rheumatology, Royal North Shore, St. Leonards, NSW, Australia; SDG LLC, Cambridge, Massachusetts; University of Alabama at Birmingham; Veterans Affairs Medical Center, Birmingham, Alabama; Mayo Clinic College of Medicine, Rochester, Minnesota; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Department of Epidemiology and Community Medicine, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
  2. M. Boers, MSC, MD, PhD, Professor of Clinical Epidemiology, Department of Epidemiology and Biostatistics, VU University Medical Center; J.R. Kirwan, MD, FRCP, Professor of Rheumatic Diseases, University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary; L. Gossec, MD, PhD, UPMC, GRC-UMPC 08 (EEMOIS), APHP, Hôpital Pitié-Salpêtrière, Rhumatologie; P.G Conaghan, Professor of Musculoskeletal Medicine, University of Leeds and NIHR Leeds, Musculoskeletal Biomedical Research Unit; M-A. D’Agostino, MD, PhD, Professor of Rheumatology, Department of Rheumatology, APHP, Ambroise Paré Hospital, UPRES EA 2506 Université; C.O. Bingham III, MD, Associate Professor of Medicine, Division of Rheumatology, Johns Hopkins University; P. Brooks, MD, Director, Australian Health Workforce Institute, School of Population, Health, University of Melbourne; R. Landewé, MD, PhD, Professor of Rheumatology, Academic Medical Center/University of Amsterdam and Atrium Medical Center Heerlen; L. March, MBBS, MSC, PhD, FRACP, FAFPHM, Director, Institute of Bone and Joint Research and Conjoint Professor, Sydney Medical School and School of Public Health, University of Sydney, and Senior Staff Specialist, Department of Rheumatology, Royal North Shore; L.S. Simon, MD, SDG LLC; J.A. Singh, MBBS, MPH, Associate Professor of Medicine and Epidemiology, University of Alabama at Birmingham, Staff Physician, Veterans Affairs Medical Center, and Research Collaborator, Mayo Clinic College of Medicine; V. Strand, MD, Clinical Professor, Adjunct, Division of Immunology/Rheumatology, Stanford University School of Medicine; G.A. Wells, PhD, Professor, Department of Epidemiology and Community Medicine, University of Ottawa; P. Tugwell, MD, MSC, FRCPC Professor, Canada Research Chair, Department of Medicine, University of Ottawa.
  1. Address correspondence to Prof. Boers, Department of Epidemiology and Biostatistics, VU University Medical Center, PK 6Z 165, PO Box 7057 1007 MB, Amsterdam, The Netherlands. E-mail: eb{at}vumc.nl

Article usage

Article usage: February 2014 to November 2023

AbstractFullPdf
Feb 2014101
Mar 2014198017
Apr 201411859
May 20142311245
Jun 2014120129
Jul 201443817
Aug 20144325
Sep 20144059
Oct 20142337
Nov 201430411
Dec 20143929
Jan 20152522
Feb 20152442
Mar 20153165
Apr 201529310
May 20151454
Jun 20154098
Jul 201530810
Aug 20151965
Sep 20151825
Oct 20152329
Nov 201523812
Dec 20151342
Jan 20162510
Feb 20162614
Mar 2016933
Apr 20162367
May 2016624
Jun 20161841
Jul 20161610
Aug 201626510
Sep 2016933
Oct 20161446
Nov 20161413
Dec 20163900
Jan 20171243
Feb 20171121
Mar 20172153
Apr 20171753
May 20172755
Jun 20171332
Jul 20171200
Aug 20171833
Sep 201719118
Oct 2017222012
Nov 201727123
Dec 20175145
Jan 20183051
Feb 201834112
Mar 20184473
Apr 20182959
May 201840612
Jun 20181936
Jul 20183037
Aug 20181536
Sep 20182686
Oct 201818717
Nov 201818216
Dec 201824713
Jan 20192284
Feb 20191784
Mar 20191902
Apr 201924111
May 20191223
Jun 201917311
Jul 20193194
Aug 20194445
Sep 20193432
Oct 20194439
Nov 201948812
Dec 20194374
Jan 202045129
Feb 2020142221
Mar 2020102216
Apr 202083432
May 202083310
Jun 202011013
Jul 202031915
Aug 202061511
Sep 20208286
Oct 20204229
Nov 20207349
Dec 202054110
Jan 202131913
Feb 2021132916
Mar 20214247
Apr 202112475
May 2021594217
Jun 202110308
Jul 20216239
Aug 202102612
Sep 20217176
Oct 202154412
Nov 20217188
Dec 202152913
Jan 20223176
Feb 202253922
Mar 202261110
Apr 202292120
May 202273217
Jun 20222204
Jul 20224256
Aug 202273311
Sep 202264614
Oct 20223237
Nov 20224235
Dec 2022086
Jan 202385310
Feb 202310156
Mar 202310157
Apr 202315199
May 202381523
Jun 20236207
Jul 202343324
Aug 202391614
Sep 202393410
Oct 202317347
Nov 2023163011

Statistics from Altmetric.com

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 41, Issue 5
1 May 2014
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
How to Choose Core Outcome Measurement Sets for Clinical Trials: OMERACT 11 Approves Filter 2.0
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
How to Choose Core Outcome Measurement Sets for Clinical Trials: OMERACT 11 Approves Filter 2.0
Maarten Boers, John R. Kirwan, Laure Gossec, Philip G. Conaghan, Maria-Antonietta D’Agostino, Clifton O. Bingham, Peter M. Brooks, Robert Landewé, Lyn March, Lee Simon, Jasvinder A. Singh, Vibeke Strand, George A. Wells, Peter Tugwell
The Journal of Rheumatology May 2014, 41 (5) 1025-1030; DOI: 10.3899/jrheum.131314

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
How to Choose Core Outcome Measurement Sets for Clinical Trials: OMERACT 11 Approves Filter 2.0
Maarten Boers, John R. Kirwan, Laure Gossec, Philip G. Conaghan, Maria-Antonietta D’Agostino, Clifton O. Bingham, Peter M. Brooks, Robert Landewé, Lyn March, Lee Simon, Jasvinder A. Singh, Vibeke Strand, George A. Wells, Peter Tugwell
The Journal of Rheumatology May 2014, 41 (5) 1025-1030; DOI: 10.3899/jrheum.131314
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • Summary of Main Filter 2.0 Session Reports
    • Final Voting
    • Next Steps
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters

Keywords

OUTCOME AND PROCESS ASSESSMENT
CLINICAL TRIALS
OMERACT FILTER
CORE OUTCOME SETS

Related Articles

Cited By...

More in this TOC Section

OMERACT 11

  • Updating the OMERACT Filter: Implications for Patient-reported Outcomes
  • Updating the OMERACT Filter: Discrimination and Feasibility
  • Can We Decide Which Outcomes Should Be Measured in Every Clinical Trial? A Scoping Review of the Existing Conceptual Frameworks and Processes to Develop Core Outcome Sets
Show more OMERACT 11

The OMERACT Filter 2.0

  • Can We Decide Which Outcomes Should Be Measured in Every Clinical Trial? A Scoping Review of the Existing Conceptual Frameworks and Processes to Develop Core Outcome Sets
  • Updating the OMERACT Filter at OMERACT 11
  • Updating the OMERACT Filter: Core Areas as a Basis for Defining Core Outcome Sets
Show more The OMERACT Filter 2.0

Similar Articles

Keywords

  • outcome and process assessment
  • clinical trials
  • OMERACT FILTER
  • CORE OUTCOME SETS

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2023 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire